{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:21:54Z","timestamp":1794385314441,"version":"4.9.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T00:00:00Z","timestamp":1389744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-5","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T19:02:06Z","timestamp":1389812526000},"source":"Crossref","is-referenced-by-count":60,"title":["The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women"],"prefix":"10.1186","volume":"11","author":[{"given":"Oliver Chukwujekwu","family":"Ezechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Olof","family":"Ostergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca Obiageri","family":"Nwaokorie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent Achaya Otobo","family":"Ujah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Odberg Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"issue":"32","key":"2351_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0968-8080(08)32415-X","volume":"16","author":"RI Anorlu","year":"2008","unstructured":"Anorlu RI: Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 2008,16(32):41-49. 10.1016\/S0968-8080(08)32415-X","journal-title":"Reprod Health Matters"},{"issue":"6","key":"2351_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jmv.20817","volume":"79","author":"DB Blossom","year":"2007","unstructured":"Blossom DB, Beigi RH, Farrell JJ, Mackay W, Qadadri B, Brown DR, Rwambuya S, Walker CJ, Kambugu FS, Abdul-Karim FW, Whalen CC, Salata RA: Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women. J Med Virol 2007,79(6):758-765. 10.1002\/jmv.20817","journal-title":"J Med Virol"},{"issue":"9","key":"2351_CR3","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.1016\/j.ijid.2010.03.016","volume":"14","author":"AE Luquea","year":"2010","unstructured":"Luquea AE, Hittib J, Mwacharic C, Lanea C, Messing S, Cohna SE, et al.: Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women\u2019s HIV Interdisciplinary Network (WHIN). Int J Infect Dis 2010,14(9):e810-e814. doi:10.1016\/j.ijid.2010.03.016 10.1016\/j.ijid.2010.03.016","journal-title":"Int J Infect Dis"},{"key":"2351_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jnci\/dji073","volume":"97","author":"HD Strickler","year":"2005","unstructured":"Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al.: Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005, 97: 577-586. 10.1093\/jnci\/dji073","journal-title":"J Natl Cancer Inst"},{"key":"2351_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1258\/ijsa.2008.008359","volume":"20","author":"E Jong","year":"2009","unstructured":"Jong E, van Gorp ECM, Mulder JW, Tol A, Smits PHM: Effect of viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV infected men. Int J STD AIDS 2009, 20: 262-264. 10.1258\/ijsa.2008.008359","journal-title":"Int J STD AIDS"},{"key":"2351_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2334-7-77","volume":"7","author":"C Ngandwe","year":"2007","unstructured":"Ngandwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC: The distribution of sexually transmitted Human Pappillomaviruses in HIV positive and negative patients in Zambia. Africa BMC Infect Dis 2007, 7: 77. doi:10.1186\/1471-2334-7-77 10.1186\/1471-2334-7-77","journal-title":"Africa BMC Infect Dis"},{"key":"2351_CR7","volume-title":"National guidelines for HIV and AIDs treatment and care in adolescents and adults","author":"Federal Ministry of Health, Nigeria (FMoH)","year":"2010","unstructured":"Federal Ministry of Health, Nigeria (FMoH): National guidelines for HIV and AIDs treatment and care in adolescents and adults. Abuja Nigeria: FMoH; 2010."},{"issue":"10","key":"2351_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/j.1365-3156.2009.02372.x","volume":"14","author":"KS Louie","year":"2009","unstructured":"Louie KS, de Sanjose S, Mayaud P: Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med int Health 2009,14(10):1287-1302. 10.1111\/j.1365-3156.2009.02372.x","journal-title":"Trop Med int Health"},{"issue":"1","key":"2351_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Mu\u00f1oz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003,88(1):63-73. 10.1038\/sj.bjc.6600688","journal-title":"Br J Cancer"},{"key":"2351_CR10","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","volume":"20","author":"GM Clifford","year":"2006","unstructured":"Clifford GM, Goncalves MAG, Franceschi S: Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20: 2337-2344. 10.1097\/01.aids.0000253361.63578.14","journal-title":"AIDS"},{"key":"2351_CR11","volume-title":"Nigerian HIV-1 substypes and resistance to first line antiretroviral therapy","author":"C Beth","year":"2010","unstructured":"Beth C, Eisen G, Meloni S, Idoko J, Onwujekwe D, Olaleye D, Gashau W, et al.: Nigerian HIV-1 substypes and resistance to first line antiretroviral therapy. Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV\/AIDS; 2010."},{"key":"2351_CR12","volume-title":"Impact of HIV type 1 protease polymorphisms in a Nigerian population","author":"K Phyllis","year":"2010","unstructured":"Phyllis K, Chaplin B, Eisen G, Meloni S, Idoko J, Onwujekwe D, et al.: Impact of HIV type 1 protease polymorphisms in a Nigerian population. Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV\/AIDS; 2010."},{"key":"2351_CR13","volume-title":"The changing pattern of HIV related deaths in south western Nigeria","author":"RA Adu","year":"2010","unstructured":"Adu RA, Ezechi OC, Onwujekwe DI, Odunukwe NN, David AN, Kalejaiye OO, et al.: The changing pattern of HIV related deaths in south western Nigeria. Abuja Nigeria: Oral Paper presentation at 5th National Conference on HIV\/AIDS; 2010."},{"issue":"Suppl 4","key":"2351_CR14","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/01.aids.0000191486.92285.1c","volume":"19","author":"DP Campos","year":"2005","unstructured":"Campos DP, Riberio SR, Grinsztejn B, Veloso VG, Valente JG, Bastos FI, et al.: Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986\u20132003. AIDS 2005,19(Suppl 4):S22-S26. 10.1097\/01.aids.0000191486.92285.1c","journal-title":"AIDS"},{"key":"2351_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijgo.2009.06.006","volume":"107","author":"PA Agaba","year":"2009","unstructured":"Agaba PA, Thacher TD, Ekwempu CC, Idoko JA: Cervical dysplasia in Nigerian women Infected with HIV. Int J Gynecol Obstet 2009, 107: 99-102. 10.1016\/j.ijgo.2009.06.006","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"2351_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/01443610500107601","volume":"25","author":"CM Chama","year":"2005","unstructured":"Chama CM, Nggada H, Gaushau W: Cervical dysplasia in HIV infected women in Maiduguri. Trop J Obstet Gynaecol 2005,25(3):286-288.","journal-title":"Trop J Obstet Gynaecol"},{"key":"2351_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00126334-199905010-00005","volume":"21","author":"LS Massad","year":"1999","unstructured":"Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al.: Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1.Women\u2019s Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999, 21: 33-41. 10.1097\/00126334-199905010-00005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2351_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","volume":"95","author":"HD Strickler","year":"2005","unstructured":"Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, et al.: Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2005, 95: 1062-1071.","journal-title":"J Natl Cancer Inst"},{"key":"2351_CR19","first-page":"689","volume":"25","author":"M Branca","year":"2004","unstructured":"Branca M, Costa S, Mariani I, Sesti F, Agarossi A, di Carlo A, et al.: Assessment of risk factors and human papillomavirus (HPV) related pathogenic mechanisms of CIN in HIV positive and HIV negative women. Study design and baseline data of the HPV Pathogen ISS study. Eur J Gynaecol Oncol 2004, 25: 689-698.","journal-title":"Eur J Gynaecol Oncol"},{"key":"2351_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/00002030-199809000-00013","volume":"12","author":"C Six","year":"1998","unstructured":"Six C, Heard I, Bergeron C, Orth G, Poveda JD, Zagury P, et al.: Comparative prevalence, incidence and short term prognosis of cervical squamous intraepithelial lesions amongst HIV positive and HIV negative women. AIDS 1998, 12: 1047-1056. 10.1097\/00002030-199809000-00013","journal-title":"AIDS"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijid.2008.03.031","volume":"13","author":"B Grinsztejn","year":"2009","unstructured":"Grinsztejn B, Veloso VGC, Levi JE, Velasque L, Luz PM, Friedman RK, Andrade AC, Moreira RI, Russomano F, Pilotto JH, Bastos FLD, Palefsky J: Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis 2009, 13: 72-80. 10.1016\/j.ijid.2008.03.031","journal-title":"Int J Infect Dis"},{"key":"2351_CR22","first-page":"7","volume":"11","author":"F Okonofua","year":"2007","unstructured":"Okonofua F: HPV vaccines and prevention of cervical cancer in Africa. Afr J Reprod Health 2007, 11: 7-9.","journal-title":"Afr J Reprod Health"},{"key":"2351_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/sj.bjc.6601515","volume":"90","author":"JO Thomas","year":"2004","unstructured":"Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJF, Meijer C, et al.: Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004, 90: 638-645. 10.1038\/sj.bjc.6601515","journal-title":"Br J Cancer"},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/ijc.26211","volume":"130","author":"JC Gage","year":"2012","unstructured":"Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M: The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer 2012, 130: 2111-2117. 10.1002\/ijc.26211","journal-title":"Int J Cancer"},{"issue":"9","key":"2351_CR25","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1128\/JCM.41.9.4451-4453.2003","volume":"41","author":"P Mayaud","year":"2003","unstructured":"Mayaud P, Weiss HA, Lacey CJN, Gill DK, Mabey DCW: Genital human papillomavirus genotypes in Northwestern Tanzania. J Clin Microbiol 2003,41(9):4451-4453. 10.1128\/JCM.41.9.4451-4453.2003","journal-title":"J Clin Microbiol"},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JMM Walboomers","year":"1999","unstructured":"Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189: 12-19. 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","journal-title":"J Pathol"},{"key":"2351_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87: 796-802. 10.1093\/jnci\/87.11.796","journal-title":"J Natl Cancer Inst"},{"key":"2351_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-9378-5-24","volume":"5","author":"C Okolo","year":"2010","unstructured":"Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJF, Meijer CJLM, Clifford GM: Human papillomavirus infection in women with and without cervical cancer in Ibadan. Niger Infect Agents Cancer 2010, 5: 24. doi:10.1186\/1750-9378-5-24 10.1186\/1750-9378-5-24","journal-title":"Niger Infect Agents Cancer"},{"key":"2351_CR29","volume-title":"National policy on cervical cancer prevention and control","author":"Federal Ministry of Health","year":"2011","unstructured":"Federal Ministry of Health: National policy on cervical cancer prevention and control. Abuja Nigeria: Federal Ministry of Health in Nigeria; 2011."},{"key":"2351_CR30","volume-title":"Antiretroviral therapy in Nigeria","author":"National Agency for the control of AIDS (NACA)","year":"2011","unstructured":"National Agency for the control of AIDS (NACA): Antiretroviral therapy in Nigeria. 2011. http:\/\/www.naca.gov.ng\/content\/view\/417\/language,en"},{"key":"2351_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2458-13-46","volume":"13","author":"OC Ezechi","year":"2013","unstructured":"Ezechi OC, Gab Okafor CV, Ostergren PO, Odberg Pettersson K: Willingness and acceptability of cervical cancer screening among HIV positive Nigerian women. BMC Public Health 2013, 13: 46. doi:10.1186\/1471-2458-13-46 10.1186\/1471-2458-13-46","journal-title":"BMC Public Health"},{"key":"2351_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1743-422X-8-514","volume":"8","author":"F Piras","year":"2011","unstructured":"Piras F, Piga M, De Montis A, Zannou AR, Minerba L, Perra MT, et al.: Prevalence of human Papillomavirus infection in women in Benin, West Africa. Virol J 2011, 8: 514. http:\/\/www.virologyj.com\/content\/8\/1\/514 10.1186\/1743-422X-8-514","journal-title":"Virol J"},{"issue":"4","key":"2351_CR33","first-page":"173","volume":"2","author":"NT Ebisi","year":"2012","unstructured":"Ebisi NT: The impacts of culture on the transmission of infection: the case of Awka South, Anambra state. Afr J Soc Sci 2012,2(4):173-190.","journal-title":"Afr J Soc Sci"},{"issue":"7","key":"2351_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S De Sanjose","year":"2007","unstructured":"De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007,7(7):453-459. 10.1016\/S1473-3099(07)70158-5","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2351_CR35","doi-asserted-by":"publisher","first-page":"e1000227","DOI":"10.1371\/journal.pmed.1000227","volume":"7","author":"GE Gray","year":"2010","unstructured":"Gray GE: Adolescent HIV\u2014Cause for Concern in Southern Africa. PLoS Med 2010,7(2):e1000227. doi:10.1371\/journal.pmed.1000227 10.1371\/journal.pmed.1000227","journal-title":"PLoS Med"},{"key":"2351_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1097\/QAD.0b013e32833016ce","volume":"23","author":"RA Ferrand","year":"2009","unstructured":"Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, et al.: AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS 2009, 23: 2039-2046. 10.1097\/QAD.0b013e32833016ce","journal-title":"AIDS"},{"key":"2351_CR37","doi-asserted-by":"publisher","first-page":"e1000178","DOI":"10.1371\/journal.pmed.1000178","volume":"7","author":"RA Ferrand","year":"2010","unstructured":"Ferrand RA, Banson T, Musvaire P, Larke N, Nathoo K, et al.: Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic. PloS Med 2010, 7: e1000178. doi:10.1371\/journal.pmed.1000178 10.1371\/journal.pmed.1000178","journal-title":"PloS Med"},{"key":"2351_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","volume":"91","author":"JM Palefsky","year":"1999","unstructured":"Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al.: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91: 226-236. 10.1093\/jnci\/91.3.226","journal-title":"J Natl Cancer Inst"},{"key":"2351_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/CEJ.0b013e3282f75ea1","volume":"17","author":"H De Vuyst","year":"2008","unstructured":"De Vuyst H, Lilloc F, Broutetd N, Smithe JS: HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008, 17: 545-554. 10.1097\/CEJ.0b013e3282f75ea1","journal-title":"Eur J Cancer Prev"},{"key":"2351_CR40","first-page":"443","volume":"106","author":"TR Broker","year":"2001","unstructured":"Broker TR, Jin G, Croom-Rivers A, Bragg SM, Richardson M, Chow LT, et al.: Viral latency \u2013 the papillomavirus model. Dev Biol 2001, 106: 443-451.","journal-title":"Dev Biol"},{"key":"2351_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135965350400900117","volume":"9","author":"I Heard","year":"2004","unstructured":"Heard I, Palefsky JM, Kazatchkine MD: The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004, 9: 13-22.","journal-title":"Antivir Ther"},{"key":"2351_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1086\/322856","volume":"184","author":"FB Lillo","year":"2001","unstructured":"Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, et al.: Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001, 184: 547-551. 10.1086\/322856","journal-title":"J Infect Dis"},{"key":"2351_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1086\/375783","volume":"188","author":"P Schuman","year":"2003","unstructured":"Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, et al.: Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003, 188: 128-136. 10.1086\/375783","journal-title":"J Infect Dis"},{"key":"2351_CR44","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/00002030-200204120-00014","volume":"16","author":"AL Moore","year":"2002","unstructured":"Moore AL, Sabin CA, Madge S, Mocroft A, Reid W, Johnson MA: Highly active antiretroviral therapy and cervical intraepithelial neoplasia. AIDS 2002, 16: 927-929. 10.1097\/00002030-200204120-00014","journal-title":"AIDS"},{"key":"2351_CR45","volume-title":"2006 Population & Housing Census Report","author":"National Population Commission, Nigeria","year":"2007","unstructured":"National Population Commission, Nigeria: 2006 Population & Housing Census Report. Abuja Nigeria; 2007. http:\/\/www.population.gov.ng\/"},{"key":"2351_CR46","first-page":"41","volume-title":"Survey Sampling","author":"L Kish","year":"1965","unstructured":"Kish L: Survey Sampling. New York: John Wiley & Sons, Inc; 1965:41."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-11-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T17:10:50Z","timestamp":1688922650000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,15]]},"article-number":"5"}}